FOLFIRI regimen for metastatic or recurrent colorectal cancer[J].Gan To Kagaku Ryoho(Japanese Journal of Cancer and Chemotherapy),2006,(7):904-906.Uemura N, Yamada Y. FOLFIRI regimen for metastatic or recurrent colorectal cancer. Gan To Kagaku Ryoho 2006; 33: 904-906...
Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial. Journal of Clinical Oncology. 2013;31(3):359-364. 2. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. New England Journal of Medicine. 2005;352(...
参考文献 Heinemann, V., von Weikersthal, L.F., Decker, T. et al. FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial....
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial[J]. Br J Cancer, 2021, 124(3): 587-594. 背景:在FIRE-3研究中,与贝...
14、orin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ.J Clin Oncol,2000,18(16):2938一2947.4. Andre T, Boni C, Mounedji2Boudiaf L, et al. Oxalip latin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med...
转移性大肠癌(metastaticcolorectalcancer,MCC) 的治疗以延长患者生存期和改善患者生活质量为目 的。多项研究证实伊立替康联合氟尿嘧啶、亚叶酸钙 (FOLFIR!方案)可作为MCC的一线治疗,使患者的 生存期得以延长,但持续的化疗严重影响了患者的生 活质量,如伊立替康引起的腹泻、肝功能不全和血液 ...
Development ofnew agents for the treatment of advanced colorectal cancer. Clin Colorectal Cancer, 2003, 3: 154- 164. 10. Tournigand C, Andre T, Achille E, et al. FOLFIR I followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol...
[1] Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal:systematic review and meta-analysis.BMJ,2000,321(7260):531. [2] De Gramont A,Bosset JF,Milan C, et al. Randomized trial comparing monthly low-dose leucovorinand fluoroueacil boluvorin bolus with bimonthly ...
colorectal cancer with hepaticmetastasis LIUJan,MAOGuoxin.DepartmentofChemotherapy,theAfiliatedHospitalofNantongUniversity,Nantong 226001,China 【Abstract】 Objective Toevaluatetheeficacyandsafetyofrh—endostatin(endostar)combinedwithFOLFIRIregimenin colorectalcancerwithhepaticmetastasis.Methods ...
[5]Douillard JY,Cunningham D,Roth AD,et al.Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer:a multicentrerandomised trial[J] .Lancet,2000,355(9 290):1 041 -1 047. [6]Des Guetz G,Uzzan B,Nicolas P,et al.Microve...